These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 30089916)

  • 41. Prognostic impact of specific molecular profiles in pediatric acute megakaryoblastic leukemia in non-Down syndrome.
    Hara Y; Shiba N; Ohki K; Tabuchi K; Yamato G; Park MJ; Tomizawa D; Kinoshita A; Shimada A; Arakawa H; Saito AM; Kiyokawa N; Tawa A; Horibe K; Taga T; Adachi S; Taki T; Hayashi Y
    Genes Chromosomes Cancer; 2017 May; 56(5):394-404. PubMed ID: 28063190
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A parsimonious 3-gene signature predicts clinical outcomes in an acute myeloid leukemia multicohort study.
    Wagner S; Vadakekolathu J; Tasian SK; Altmann H; Bornhäuser M; Pockley AG; Ball GR; Rutella S
    Blood Adv; 2019 Apr; 3(8):1330-1346. PubMed ID: 31015209
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expression of mitochondrial genes predicts survival in pediatric acute myeloid leukemia.
    Tyagi A; Pramanik R; Bakhshi R; Singh A; Vishnubhatla S; Bakhshi S
    Int J Hematol; 2019 Aug; 110(2):205-212. PubMed ID: 31119613
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A three-gene signature might predict prognosis in patients with acute myeloid leukemia.
    Zhu X; Zhao Q; Su X; Ke J; Yi Y; Yi J; Lin J; Qian J; Deng Z
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32436945
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Development and validation of GMI signature based random survival forest prognosis model to predict clinical outcome in acute myeloid leukemia.
    Shi M; Xu G
    BMC Med Genomics; 2019 Jun; 12(1):90. PubMed ID: 31242922
    [TBL] [Abstract][Full Text] [Related]  

  • 46. CD45 correlates with adverse risk stratification, decreased treatment response and unfavorable survival profiles in elderly acute myeloid leukemia patients.
    Guo L; Chen L; Wang H
    Cancer Biomark; 2018; 23(3):455-463. PubMed ID: 30347598
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gene expression profiling in the leukemic stem cell-enriched CD34+ fraction identifies target genes that predict prognosis in normal karyotype AML.
    de Jonge HJ; Woolthuis CM; Vos AZ; Mulder A; van den Berg E; Kluin PM; van der Weide K; de Bont ES; Huls G; Vellenga E; Schuringa JJ
    Leukemia; 2011 Dec; 25(12):1825-33. PubMed ID: 21760593
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognostic implications of CEBPA mutations in pediatric acute myeloid leukemia: a report from the Japanese Pediatric Leukemia/Lymphoma Study Group.
    Matsuo H; Kajihara M; Tomizawa D; Watanabe T; Saito AM; Fujimoto J; Horibe K; Kodama K; Tokumasu M; Itoh H; Nakayama H; Kinoshita A; Taga T; Tawa A; Taki T; Tanaka S; Adachi S
    Blood Cancer J; 2014 Jul; 4(7):e226. PubMed ID: 25014773
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Development and validation of a 10-gene prognostic signature for acute myeloid leukaemia.
    Yang Z; Shang J; Li N; Zhang L; Tang T; Tian G; Chen X
    J Cell Mol Med; 2020 Apr; 24(8):4510-4523. PubMed ID: 32150667
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The prognostic impact of tet oncogene family member 2 mutations in patients with acute myeloid leukemia: a systematic-review and meta-analysis.
    Wang R; Gao X; Yu L
    BMC Cancer; 2019 Apr; 19(1):389. PubMed ID: 31023266
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association of a murine leukaemia stem cell gene signature based on nucleostemin promoter activity with prognosis of acute myeloid leukaemia in patients.
    Ali MA; Naka K; Yoshida A; Fuse K; Kasada A; Hoshii T; Tadokoro Y; Ueno M; Ohta K; Kobayashi M; Takahashi C; Hirao A
    Biochem Biophys Res Commun; 2014 Jul; 450(1):837-43. PubMed ID: 24960197
    [TBL] [Abstract][Full Text] [Related]  

  • 52. High EVI1 expression predicts outcome in younger adult patients with acute myeloid leukemia and is associated with distinct cytogenetic abnormalities.
    Gröschel S; Lugthart S; Schlenk RF; Valk PJ; Eiwen K; Goudswaard C; van Putten WJ; Kayser S; Verdonck LF; Lübbert M; Ossenkoppele GJ; Germing U; Schmidt-Wolf I; Schlegelberger B; Krauter J; Ganser A; Döhner H; Löwenberg B; Döhner K; Delwel R
    J Clin Oncol; 2010 Apr; 28(12):2101-7. PubMed ID: 20308656
    [TBL] [Abstract][Full Text] [Related]  

  • 53.
    Elsherif M; Hammad M; Hafez H; Yassin D; Ashraf M; Yasser N; Lehmann L; Elhaddad A
    Acta Oncol; 2022 Apr; 61(4):516-522. PubMed ID: 35038958
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High expression of inositol 1,4,5-trisphosphate receptor, type 2 (ITPR2) as a novel biomarker for worse prognosis in cytogenetically normal acute myeloid leukemia.
    Shi JL; Fu L; Wang WD
    Oncotarget; 2015 Mar; 6(7):5299-309. PubMed ID: 25779662
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CircRNF220, not its linear cognate gene RNF220, regulates cell growth and is associated with relapse in pediatric acute myeloid leukemia.
    Liu X; Liu X; Cai M; Luo A; He Y; Liu S; Zhang X; Yang X; Xu L; Jiang H
    Mol Cancer; 2021 Oct; 20(1):139. PubMed ID: 34702297
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Myeloid sarcoma is associated with poor clinical outcome in pediatric patients with acute myeloid leukemia.
    Xu LH; Wang Y; Chen ZY; Fang JP
    J Cancer Res Clin Oncol; 2020 Apr; 146(4):1011-1020. PubMed ID: 31919567
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical features and prognosis of normal karyotype acute myeloid leukemia pediatric patients with WT1 mutations: an analysis based on TCGA database.
    Xu J; Zhang Y; Hu J; Ren Y; Wang H
    Hematology; 2020 Dec; 25(1):79-84. PubMed ID: 32019476
    [No Abstract]   [Full Text] [Related]  

  • 58. High VEGFC expression is associated with unique gene expression profiles and predicts adverse prognosis in pediatric and adult acute myeloid leukemia.
    de Jonge HJ; Valk PJ; Veeger NJ; ter Elst A; den Boer ML; Cloos J; de Haas V; van den Heuvel-Eibrink MM; Kaspers GJ; Zwaan CM; Kamps WA; Löwenberg B; de Bont ES
    Blood; 2010 Sep; 116(10):1747-54. PubMed ID: 20522712
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A three-gene signature and clinical outcome in pediatric acute myeloid leukemia.
    Cai Z; Wu Y; Zhang F; Wu H
    Clin Transl Oncol; 2021 Apr; 23(4):866-873. PubMed ID: 32862280
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Overexpression of ATP1B1 predicts an adverse prognosis in cytogenetically normal acute myeloid leukemia.
    Shi JL; Fu L; Ang Q; Wang GJ; Zhu J; Wang WD
    Oncotarget; 2016 Jan; 7(3):2585-95. PubMed ID: 26506237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.